Search

Your search keyword '"Kumada, Hiromitsu"' showing total 318 results

Search Constraints

Start Over You searched for: Author "Kumada, Hiromitsu" Remove constraint Author: "Kumada, Hiromitsu" Journal hepatology research Remove constraint Journal: hepatology research
318 results on '"Kumada, Hiromitsu"'

Search Results

1. A new imaging classification for safer radial access visceral intervention of the liver and optimal case selection: A preliminary report

2. Impact of genetic polymorphism on personalized diet and exercise program for steatotic liver disease.

3. Impact of genetic polymorphism to personalized diet and exercise program for steatotic liver disease

4. Impact of fibrosis on liver‐related event incidence in nonalcoholic fatty liver disease: A multicenter observational study

5. Treatment efficacy of diet and exercise program for fatty liver and pretreatment predictors

6. Sofosbuvir–velpatasvir in adults with hepatitis C virus infection and compensated cirrhosis in Japan

13. Renal safety and biochemical changes for two years of tenofovir alafenamide after switching from long‐term other nucleotide analogues treatment in patients with chronic hepatitis B

25. Potential of ultra‐highly sensitive immunoassays for hepatitis B surface and core‐related antigens in patients with or without development of hepatocellular carcinoma after hepatitis B surface antigen seroclearance

26. Virologic analysis of tenofovir resistance in a patient with chronic hepatitis B experiencing viral breakthrough during combination treatment with tenofovir disoproxil fumarate and entecavir

28. Efficacy and safety in sitagliptin therapy for diabetes complicated by non-alcoholic fatty liver disease

29. Effects of alcohol consumption on multiple hepatocarcinogenesis in patients with fatty liver disease

33. Exploratory study on telaprevir given every 8 h at 500 mg or 750 mg with peginterferon-alpha-2b and ribavirin in hepatitis C patients

37. Renal safety and biochemical changes for 2 years after switching to tenofovir alafenamide from long‐term other nucleotide analog treatment in patients with chronic hepatitis B.

40. Difference in malignancies of chronic liver disease due to non-alcoholic fatty liver disease or hepatitis C in Japanese elderly patients

41. Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B

45. Efficacy and safety in sitagliptin therapy for diabetes complicated by chronic liver disease caused by hepatitis C virus

47. Advantage of liver stiffness measurement before and after direct‐acting antiviral therapy to predict hepatocellular carcinoma and exacerbation of esophageal varices in chronic hepatitis C

Catalog

Books, media, physical & digital resources